myriad genetics inc (MYGN:NASDAQ GS)
Mark H. Skolnick Ph.D.
Former Chief Scientific Officer and Director, Myriad Genetics Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 4 different industries.|
Mr. Mark H. Skolnick Ph.D. was a Scientific Founder of Myriad Genetics Inc. and served as its Chief Scientific Officer since 1997. Dr. Skolnick served as Executive Vice President of Research and Development of Myriad Genetics Inc. from 1991 to July 2000. Dr. Skolnick directed the group that cloned the breast cancer susceptibility gene, BRCA1; found the full-length sequence of BRCA2; cloned the MMAC1 (PTEN) tumor suppressor gene; cloned a prostate cancer gene (HPC2); ...
320 Wakara WayPhone: 801-584-3600
Salt Lake City, Utah 84108
Board Members Memberships*There is no Board Members Memberships data available.
University of California Berkeley
University of California
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Frank S. Hermance||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Jen-Hsun Huang||Co-Founder, Chief Executive Officer, President, Director and Member of Compensation Committee|
|Carlo Bozotti||Chairman of Management Board, Chief Executive Officer, President and Chairman of Corporate Strategic Committee|
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Hisashi Ietsugu||Chairman of the Managing Board, Chief Executive Officer, President, Member of Global Strategic Committee, Member of Group Management Reporting Committee and Member of Steering Committee|
|¥250.0M||Compensation as of Fiscal Year 2014.|